Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis
暂无分享,去创建一个
[1] D. Sacks,et al. CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.
[2] Richard A. Flavell,et al. Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.
[3] P. Kaye,et al. Distinct roles for IL‐6 and IL‐12p40 in mediating protection against Leishmania donovani and the expansion of IL‐10+ CD4+ T cells , 2006, European journal of immunology.
[4] Y. Belkaid,et al. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens , 2006, The Journal of experimental medicine.
[5] C. Brodskyn,et al. Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis , 2005, BMC infectious diseases.
[6] F. Miedema,et al. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani. , 2005, Clinical immunology.
[7] R. Sinden,et al. Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. , 2005, Immunity.
[8] A. Thornton. T regulatory cells , 2005, Current Biology.
[9] K. Flanders,et al. Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis , 2005, Infection and Immunity.
[10] S. Vowler,et al. Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection , 2005, Journal of Virology.
[11] S. Sundar,et al. Immunostimulatory cellular responses of cured Leishmania‐infected patients and hamsters against the integral membrane proteins and non‐membranous soluble proteins of a recent clinical isolate of Leishmania donovani , 2005, Clinical and experimental immunology.
[12] N. Shire,et al. Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients 1 , 2005, The Journal of Immunology.
[13] D. Mosser,et al. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania , 2005, The Journal of experimental medicine.
[14] A. Rudensky,et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.
[15] P. Kaye,et al. The fate of heterologous CD4+ T cells during Leishmania donovani infection , 2005, European Journal of Immunology.
[16] A. O’Garra,et al. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.
[17] Y. Lévy,et al. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. , 2004, Blood.
[18] S. Sakaguchi,et al. CD4+ Tregs and immune control. , 2004, The Journal of clinical investigation.
[19] K. Mills,et al. Regulatory T cells: friend or foe in immunity to infection? , 2004, Nature Reviews Immunology.
[20] Chen Liu,et al. An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection , 2004, Hepatology.
[21] S. Ziegler,et al. CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status , 2004, The Journal of experimental medicine.
[22] G. Cattoretti,et al. Flow cytometric analysis of normal and reactive spleen , 2004, Modern Pathology.
[23] P. Kourilsky,et al. Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1 , 2004, The Journal of Immunology.
[24] D. Nixon,et al. Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens , 2004, Journal of Virology.
[25] A. Moreira,et al. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. , 2003, The Journal of infectious diseases.
[26] Damien Chaussabel,et al. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. , 2003, Blood.
[27] A. Svennerholm,et al. Helicobacterpylori-Specific CD4+ CD25high Regulatory T Cells Suppress Memory T-Cell Responses to H. pylori in Infected Individuals , 2003, Infection and Immunity.
[28] Y. Belkaid,et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.
[29] S. Sundar,et al. Advances in the treatment of leishmaniasis , 2002, Current opinion in infectious diseases.
[30] A. Sher,et al. Bacteria-triggered CD4+ T Regulatory Cells Suppress Helicobacter hepaticus–induced Colitis , 2002, The Journal of experimental medicine.
[31] S. Sundar,et al. Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis , 2002, Annals of tropical medicine and parasitology.
[32] Y. Belkaid,et al. The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.
[33] C. Hunter,et al. IL‐10 mediates susceptibility to Leishmania donovani infection , 2001, European journal of immunology.
[34] A. Tabares,et al. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. , 2001, Experimental parasitology.
[35] M. Roncarolo,et al. Type 1 T regulatory cells , 2001, Immunological reviews.
[36] V. Boussiotis,et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.
[37] G. Trinchieri,et al. CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .
[38] S. Sundar,et al. Splenic cytokine responses in Indian kala-azar before and after treatment. , 1998, The Journal of infectious diseases.
[39] A. Steere,et al. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. , 1998, Journal of immunology.
[40] G. Trinchieri,et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10 , 1996, The Journal of experimental medicine.
[41] G. Trinchieri,et al. IL-12 enhances Th1-type responses in human Leishmania donovani infections. , 1995, Journal of immunology.
[42] S. Reed,et al. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. , 1994, Journal of immunology.
[43] N. Berhe,et al. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. , 1993, The Journal of infectious diseases.
[44] Mohamed,et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. , 1993, The Journal of clinical investigation.
[45] Wynn,et al. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. , 1993, The Journal of clinical investigation.
[46] A. White,et al. Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection. , 1992, The American journal of tropical medicine and hygiene.
[47] R. Gupta,et al. Clinico-hematological characteristics in patients with kala azar. A study from north-west India. , 1991, Tropical and geographical medicine.
[48] A. Sher,et al. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. , 1987, Journal of immunology.
[49] D. Sacks,et al. An analysis of T cell responsiveness in Indian kala-azar. , 1987, Journal of immunology.
[50] A. Bryceson,et al. Immunosuppression in Kenyan visceral leishmaniasis. , 1983, Clinical and experimental immunology.
[51] B. Veress,et al. Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. , 1977, Immunology.
[52] N. Shire,et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. , 2005, Journal of immunology.
[53] C. Corbett,et al. Serum cytokine profile in the subclinical form of visceral leishmaniasis. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[54] P. Kaye,et al. Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[55] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[56] R. Salomão,et al. Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis. , 1998, Revista do Instituto de Medicina Tropical de Sao Paulo.
[57] N. Krishnani,et al. Fine needle aspiration cytology of the spleen in visceral leishmaniasis. , 1993, Acta cytologica.